Back to search

Article

Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinoma

2022-02-02

Abstract excerpt

<title>Abstract</title> <p>Hepatocellular carcinoma (HCC) remains an incurable malignancy despite the treatment methods being continually updated. Matrix metalloproteinases (MMPs) promote the progression of HCC; however, no consensus exists on which MMP plays the predominant role in HCCs. In the present study, we analyzed differentially expressed genes in HCCs, especially MMPs, compared with adjacent tissues usin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
55591136-ec15-57b8-adb3-3336551ccd17
DOI
10.21203/rs.3.rs-1265614/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinomaDOI 10.21203/rs.3.rs-1265614/v1
Select a neighboring publication to make it the new centre.